Does APIXABAN Cause Thrombocytopenia? 967 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 967 reports of Thrombocytopenia have been filed in association with APIXABAN (ELIQUIS). This represents 0.6% of all adverse event reports for APIXABAN.
967
Reports of Thrombocytopenia with APIXABAN
0.6%
of all APIXABAN reports
133
Deaths
511
Hospitalizations
How Dangerous Is Thrombocytopenia From APIXABAN?
Of the 967 reports, 133 (13.8%) resulted in death, 511 (52.8%) required hospitalization, and 136 (14.1%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for APIXABAN.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which APIXABAN Alternatives Have Lower Thrombocytopenia Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ